Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophilia

Thromb Res. 2020 Dec:196:539-540. doi: 10.1016/j.thromres.2020.10.020. Epub 2020 Oct 20.

Authors

Alessandra Serrao¹, Laura Ballotta¹, Francesco Dragoni¹, Agnese Pallotta¹, Antonio Chistolini²

Affiliations

¹ Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Italy.
² Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Italy. Electronic address: antonio.chistolini@uniroma1.it.

PMID: 33126052
DOI: 10.1016/j.thromres.2020.10.020

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants / therapeutic use
Humans
Thrombophilia* / complications
Thrombophilia* / drug therapy
Venous Thromboembolism* / drug therapy
Venous Thromboembolism* / prevention & control

Substances

Anticoagulants